Dawn Buchanan Email
VP Clinical Operations . AffyImmune Therapeutics
Natick, MA
LocationPrimary Email
How to contact Dawn Buchanan
Join and see Dawn's contact info for free!Current Roles
Employees:
40Revenue:
$3.1MAbout
Founded in 2016, AffyImmune is a clinical-stage biotechnology company that optimizes CAR T cells for the treatment of solid tumors using our Tune & Track platform. AIC100, our first product, spares healthy cells through our unique affinity-tuning, enhancing its safety and efficacy. The initial indication for AIC100 is refractory thyroid cancer, which has a very poor prognosis and very few effective therapies. The antigen targeted by AIC100 is also overexpressed in a variety of additional cancers, including stomach, triple negative breast cancer and a number of others.AffyImmune Therapeutics Address
22 Strathmore RoadNatick, MA
United States